CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
出版年份 2016 全文链接
标题
CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
作者
关键词
-
出版物
ONCOGENE
Volume 36, Issue 9, Pages 1211-1222
出版商
Springer Nature
发表日期
2016-09-26
DOI
10.1038/onc.2016.284
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomas
- (2015) Tina Gruosso et al. Nature Communications
- Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
- (2015) Sixian Liang et al. Oncotarget
- Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers
- (2014) Sylvain Lefort et al. Autophagy
- Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis
- (2014) Zhigang Zhang et al. BMC CANCER
- The role of reactive oxygen species and metabolism on cancer cells and their microenvironment
- (2014) Ana Costa et al. SEMINARS IN CANCER BIOLOGY
- Transgene expression study of CXCR4 active mutants
- (2014) Menka Sharma et al. Cell Adhesion & Migration
- The impact of chemokine receptor CXCR4 on breast cancer prognosis: A meta-analysis
- (2013) Tong-peng Xu et al. Cancer Epidemiology
- The CXCR4 Antagonist AMD3465 Regulates Oncogenic Signaling and Invasiveness In Vitro and Prevents Breast Cancer Growth and Metastasis In Vivo
- (2013) Xiaoyang Ling et al. PLoS One
- CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization
- (2011) S. Liekens et al. CURRENT PHARMACEUTICAL DESIGN
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer
- (2010) Balraj Singh et al. CLINICAL & EXPERIMENTAL METASTASIS
- Oxidative stress promotes myofibroblast differentiation and tumour spreading
- (2010) Aurore Toullec et al. EMBO Molecular Medicine
- CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
- (2010) Saima Hassan et al. INTERNATIONAL JOURNAL OF CANCER
- Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk
- (2010) Lyndsay V Rhodes et al. Molecular Cancer
- A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer
- (2008) Eugene H. Huang et al. JOURNAL OF SURGICAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started